Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of α-interferon and oral tegafur/uracil

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 12, 2000, Pages 1447-1451

  Miyamoto, Atsushi ^a   Umeshita, Koji ^a   Sakon, Masato ^a   Nagano, Hiroaki ^a   Eguchi, Hidetoshi ^a   Kishimoto, Shin Ichi ^a   Dono, Keizo ^a   Nakamori, Shoji ^a   Gotoh, Mitsukazu ^b   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Hiroshima Prefectural Univ   (Japan)

Author keywords

Advanced hepatocellular carcinoma; Chemotherapy; Distant metastasis; interferon

Indexed keywords

ALPHA INTERFERON; DECARBOXYPROTHROMBIN; FLUOROURACIL; TEGAFUR; URACIL;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; LIVER RESECTION; LUNG NODULE; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR RECURRENCE;

EID: 0034526714     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02289.x     Document Type: Article

References (18)

1. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
2. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma
3. Microwave coagulonecrotic therapy for hepatocellular carcinoma
4. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan
5. Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b
6. Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinoma
7. No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinoma
8. Chemotherapy for advanced hepatocellular carcinoma: Adriamycin versus quadruple chemotherapy
9. Hepatobiliary cancer
10. Recombinant interferon-alpha in inoperable hepatocellular carcinoma: A randomized controlled trial
11. Effects of human immune interferon on cell viability, (2′, 5′)oligoadenylate synthesis, and polyamine-dependent protein phosphorylation in human colon carcinoma cells in vitro
12. Natural killer (NK) cell activity and its in vitro response to interferon-alpha (Le) in chronic liver diseases and hepatocellular carcinoma
13. Inhibition of basic growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration
14. Phase I and II studies on a mixture of 1-(2-tetrahydrofulyl)-5-fluorouracil and uracil (UFT)
15. Intratumorous 5-FU concentrations after coadministration of FT-207 with uracil
16. Mechanism-based improvement in the therapeutic selectivity of 5-FU prodrug alone and under conditions of metabolic modulation
17. Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo
18. A case of advanced hepatocellular carcinoma, in which the tumor almost disappeared by orally administered UFT